Show simple item record

dc.contributor.authorSafran, N.
dc.contributor.authorUzun, Hafize
dc.contributor.authorMercanoglu, F.
dc.contributor.authorAhishali, B. B.
dc.contributor.authorYalcin, A.
dc.contributor.authorMercanoglu, G.
dc.date.accessioned2021-03-05T15:39:59Z
dc.date.available2021-03-05T15:39:59Z
dc.date.issued2015
dc.identifier.citationMercanoglu G., Safran N., Ahishali B. B. , Uzun H., Yalcin A., Mercanoglu F., "Nitric oxide mediated effects of nebivolol in myocardial infarction: the source of nitric oxide", EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.19, ss.4872-4889, 2015
dc.identifier.issn1128-3602
dc.identifier.otherav_bcdf4321-173e-429b-a2cb-cce80412bedd
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/125539
dc.description.abstractOBJECTIVE: After MI pathological LV remodeling is one of the major causes of death. We previously showed the NO mediated beneficial effects of nebivolol in rat MI model, in this study we aimed to evaluate the NOS related mechanisms in this phenomenon.
dc.language.isoeng
dc.subjectYaşam Bilimleri
dc.subjectEczacılık
dc.subjectTemel Bilimler
dc.subjectSağlık Bilimleri
dc.subjectTemel Eczacılık Bilimleri
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.titleNitric oxide mediated effects of nebivolol in myocardial infarction: the source of nitric oxide
dc.typeMakale
dc.relation.journalEUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
dc.contributor.departmentBiruni Üniversitesi , ,
dc.identifier.volume19
dc.identifier.issue24
dc.identifier.startpage4872
dc.identifier.endpage4889
dc.contributor.firstauthorID19397


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record